AFT Pharmaceuticals Limited (NZE:AFT)
3.750
0.00 (0.00%)
Dec 5, 2025, 4:42 PM NZST
AFT Pharmaceuticals Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 393 | 282 | 328 | 363 | 378 | 518 | Upgrade
|
| Market Cap Growth | 47.64% | -14.06% | -9.54% | -4.00% | -26.99% | 46.56% | Upgrade
|
| Enterprise Value | 418 | 305 | 363 | 395 | 414 | 556 | Upgrade
|
| Last Close Price | 3.75 | 2.67 | 3.09 | 3.41 | 3.56 | 4.88 | Upgrade
|
| PE Ratio | 23.18 | 23.58 | 21.03 | 34.06 | 19.04 | 68.17 | Upgrade
|
| Forward PE | 23.67 | 16.79 | 19.41 | 19.12 | 18.43 | 30.80 | Upgrade
|
| PS Ratio | 1.66 | 1.36 | 1.68 | 2.32 | 2.90 | 4.58 | Upgrade
|
| PB Ratio | 4.01 | 2.91 | 3.74 | 4.95 | 6.07 | 14.15 | Upgrade
|
| P/TBV Ratio | 10.15 | 3.36 | 4.47 | 6.35 | 8.16 | 24.65 | Upgrade
|
| P/FCF Ratio | 43.20 | 21.88 | 11.42 | 31.74 | 27.34 | 787.96 | Upgrade
|
| P/OCF Ratio | 42.29 | 21.41 | 11.37 | 31.20 | 26.71 | 690.25 | Upgrade
|
| PEG Ratio | 0.65 | 0.82 | 0.54 | 1.61 | 0.38 | - | Upgrade
|
| EV/Sales Ratio | 1.77 | 1.47 | 1.86 | 2.52 | 3.18 | 4.92 | Upgrade
|
| EV/EBITDA Ratio | 16.03 | 16.92 | 14.74 | 19.89 | 20.04 | 50.70 | Upgrade
|
| EV/EBIT Ratio | 17.28 | 17.27 | 14.98 | 20.10 | 20.31 | 51.93 | Upgrade
|
| EV/FCF Ratio | 45.90 | 23.64 | 12.63 | 34.58 | 29.96 | 846.29 | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.31 | 0.37 | 0.52 | 0.65 | 1.15 | Upgrade
|
| Debt / EBITDA Ratio | 1.45 | 1.59 | 1.27 | 1.85 | 1.90 | 3.61 | Upgrade
|
| Debt / FCF Ratio | 4.16 | 2.33 | 1.12 | 3.33 | 2.93 | 64.26 | Upgrade
|
| Asset Turnover | 1.48 | 1.24 | 1.25 | 1.14 | 1.12 | 1.18 | Upgrade
|
| Inventory Turnover | 2.48 | 2.38 | 2.34 | 2.21 | 2.04 | 2.28 | Upgrade
|
| Quick Ratio | 0.69 | 1.25 | 1.15 | 1.12 | 1.30 | 1.01 | Upgrade
|
| Current Ratio | 1.51 | 2.51 | 2.30 | 2.38 | 2.67 | 2.12 | Upgrade
|
| Return on Equity (ROE) | 18.27% | 12.33% | 19.38% | 15.72% | 40.14% | 28.91% | Upgrade
|
| Return on Assets (ROA) | 9.46% | 6.58% | 9.67% | 8.93% | 10.96% | 6.97% | Upgrade
|
| Return on Capital (ROIC) | 11.95% | 8.93% | 13.10% | 11.48% | 14.03% | 9.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 24.00% | 13.90% | 20.30% | 18.20% | 20.70% | 14.70% | Upgrade
|
| Earnings Yield | 4.44% | 4.24% | 4.75% | 2.94% | 5.25% | 1.50% | Upgrade
|
| FCF Yield | 2.32% | 4.57% | 8.76% | 3.15% | 3.66% | 0.13% | Upgrade
|
| Dividend Yield | 0.48% | 0.67% | 0.52% | 0.32% | - | - | Upgrade
|
| Payout Ratio | 10.82% | 14.03% | 7.39% | - | - | 2.42% | Upgrade
|
| Buyback Yield / Dilution | 7.83% | - | -0.02% | -0.16% | -1.34% | -6.15% | Upgrade
|
| Total Shareholder Return | 8.31% | 0.67% | 0.50% | 0.16% | -1.34% | -6.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.